🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very important study! One of the main criticisms of Gem/Doce is that "all the data is retrospective" This prospective study has results that are even better (92% CR at 1 year) Looking forward to larger studies and BRIDGE results

NYU Langone Health pioneers a first-in-the-nation robotic surgery to treat urethral damage caused by radiation. Using small bowel tissue & microsurgery, Lee Zhao offers a game-changing alternative to bladder removal. Learn more: physicianfocus.nyulangone.org/a-new-option-f…

Curious as to practice patterns for low-volume CIS (partial response) at 3 month evaluation after Gem/Doce? (Let’s assume not on BRIDGE trial or any BCG shortage) A rare scenario but interesting as to whether to “save” the BCG for later… Bladder Cancer Advocacy Network YUO Saum Ghodoussipour

Maximal urethra preservation robotic prostatectomy -- 🎯Precision surgery tailored for patients with no periurethral cancer on MRI/biopsy. ⚖️Balancing oncologic control and quality of life.

Great having you NYU Langone Health NYU Langone Urology last month. Not many surgeons get the chance to bring their dad to work—let alone have him watch them in action!

Proud to announce we won best video at #SESAUA25 Great job Yeonsoo Sara Lee, MD for making the presentation and the illustrations. Also, a huge thanks to Dr. J. Kaouk for paving the way. This approach yields fast and early return to continence (55% w/in 1 week of catheter removal)

Robotic Radical Right Nephrectomy & Level 2 Caval Thrombectomy for Kidney Cancer 👨‍⚕️🤖 These complex procedures don’t come around often. Challenging? Yes. But the reward when done right? Unmatched. 💪 🔗 Watch the full-length video: youtu.be/65TPPUnE2z8

A wise doctor once told me, “WRVU stands for Worry Relative Value Units.” Thought it was just burnout poetry, turns out there is basis to create a billing code for emotional damage now.

Huge congrats to the bossman on receiving the 2025 Ferdinand C. Valentine Medal — a well-deserved honor for a true legend in the field. Proud to see him standing among giants (and holding his own). New York Section AUA Amer. Urol. Assn. NYU Grossman School of Medicine NYU Langone Urology NYU Langone Health

Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great Saum Ghodoussipour & all ⭐️ colleagues in European Urology Beautiful figures too! A valuable resource for patients & urologists Bladder Cancer Advocacy Network YUO pubmed.ncbi.nlm.nih.gov/40253283/

If this was Squid Game and it’s the cookie challenge, just shoot me already. #AUA2025 #SquidGame

Excited to see my friend Vignesh Packiam, MD present at #AUA25 on Gem/Doce for NMIBC. Gem/doce is well tolerated, highly effective, cost effective. 🦾

Is focal therapy ready for prime time? Samir Taneja says YES — with careful candidate selection, complete treatment of the index lesion, and rigorous follow-up. Exciting vision for the future of prostate cancer care! NYU Langone Urology Focal Therapy Society #AUA25

Great lectures at the World Chinese Urological Society meeting during AUA in Las Vegas — @drtanwp from NYU on techniques to achieve painless transperineal prostate biopsy. #AUA25 #Urology

Wei Phin Tan, MD, MHS Samir Taneja NYU Langone Urology Focal Therapy Society Great debate 🗣️ at #AUA25! Lara Rodríguez Sánchez Hashim U. Ahmed Edward Schaeffer, MD, PhD @tanejauroIs Is focal therapy the right fit for all intermediate-risk prostate cancer cases? 🩺 Read the written conference summary 📝 on UroToday✍️ by Julian Chavarriaga ➡️ bit.ly/4lPQzBs

Amir Lebastchi, MD shows why focal therapy is preferred for favorable intermediate-risk prostate cancer: •Radical tx doesn’t lower mortality •Hurts QOL •50% of patients on AS ends up getting treated by 8 years Focal therapy = effective, less invasive, better QOL. #AUA25 Society of Urologic Oncology

Congratulations Thomas Polascik for his recognition as the founding president of the FTS and his never ending commitment to the future of the field. #focaltherapy Duke Urology Duke University Rafael Sanchez-Salas Dr. Art Rastinehad DR. FERNANDO BIANCO Kae Jack Tay Endourological Society Amer. Urol. Assn.

Great start to Visiting Professor today NYU Langone Urology with Stephen Boorjian, MD. The NYU Urology Residency are going to learn so much and enjoy the day learning and presenting cases.